Skip to main content
. 2012 Oct 3;14(5):e126. doi: 10.2196/jmir.2216

Table 3.

Effects reported in monitoring with clinical support randomized controlled trials of acceptable quality of electronic symptom reporting, in alphabetic order of first authora.

Article Primary
outcome
Intervention
hypothesis
relative to
control
Number at
randomizationb
Within-group
pre–post changeb
Between-group
pre–post changeb,c
Hypothesis confirmed?
C I1 I2 C I1 I2 C-I1 C-I2
Carrasco et al [52] Number of patients exhibiting poor hypertension control Superior 143 142 NAd 64.3% 68.3% NA –4.0%
P = .47
NA No
Guendelman et al [44] Patients experiencing limitations in activity due to asthma last 14 days Superior 68 66 NA 25% 35% NA –9%
P = .03
NA Yes
Lewis et al [49] Number of hospitalizations Superior 20 20 NA –7 –4 NA –3
P = .16
NA No
Rasmussen et al [47] FEV1 e Superior 100 100 100 0.004 0.187 0.035 –0.183
P < .001
–0.031
Nonsignificant
I1: Yes
Schwarz et al [54] Mean number of hospital readmissions in group Superior 51 51 NA –0.33 –0.32 NA –0.01
P = .9
NA No
Willems et al [48] Asthma-specific quality of life Superior 54 55 NA –0.06 –0.29 NA 0.23
P = .386
NA No

a Articles were identified in a comprehensive search in Medline, EMBASE, PsycINFO, Cochrane Central Register of Controlled Trials, and IEEE Xplore from 1990 to November 2011, and were published in the time period 2002–2011.

b C = control group, I1 = intervention group 1, I2 = intervention group 2.

c P values for difference between groups.

d Not applicable.

e Forced expiratory volume of air in the first second of expiration.